Snapshot
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global Radiopharmaceutical market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Radiopharmaceutical by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
SPECT Radioisotopes
PET Radioisotopes
Other Diagnostic Radioisotopes
Therapeutic Radioisotopes
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Bayer
Triad Isotopes
Lantheus
GE Healthcare
Mallinckrodt
Eli Lilly
Bracco Imaging
SIEMENS
Navidea
Nordion
IBA Group
Jubilant Pharma
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Oncology
Cardiology
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Radiopharmaceutical Industry
Figure Radiopharmaceutical Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Radiopharmaceutical
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Radiopharmaceutical
1.2.2 Downstream
Table Application Segment of Radiopharmaceutical
Table Global Radiopharmaceutical Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Radiopharmaceutical Market by Type
3.1 By Type
3.1.1 SPECT Radioisotopes
Table Major Company List of SPECT Radioisotopes
3.1.2 PET Radioisotopes
Table Major Company List of PET Radioisotopes
3.1.3 Other Diagnostic Radioisotopes
Table Major Company List of Other Diagnostic Radioisotopes
3.1.4 Therapeutic Radioisotopes
Table Major Company List of Therapeutic Radioisotopes
3.2 Market Size
Table Global Radiopharmaceutical Market 2016-2020, by Type, in USD Million
Figure Global Radiopharmaceutical Market Growth 2016-2020, by Type, in USD Million
3.3 Market Forecast
Table Global Radiopharmaceutical Market Forecast 2021-2026, by Type, in USD Million
4 Major Companies List
4.1 Bayer (Company Profile, Sales Data etc.)
4.1.1 Bayer Profile
Table Bayer Overview List
4.1.2 Bayer Products & Services
4.1.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Triad Isotopes (Company Profile, Sales Data etc.)
4.2.1 Triad Isotopes Profile
Table Triad Isotopes Overview List
4.2.2 Triad Isotopes Products & Services
4.2.3 Triad Isotopes Business Operation Conditions
Table Business Operation of Triad Isotopes (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Lantheus (Company Profile, Sales Data etc.)
4.3.1 Lantheus Profile
Table Lantheus Overview List
4.3.2 Lantheus Products & Services
4.3.3 Lantheus Business Operation Conditions
Table Business Operation of Lantheus (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 GE Healthcare (Company Profile, Sales Data etc.)
4.4.1 GE Healthcare Profile
Table GE Healthcare Overview List
4.4.2 GE Healthcare Products & Services
4.4.3 GE Healthcare Business Operation Conditions
Table Business Operation of GE Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Mallinckrodt (Company Profile, Sales Data etc.)
4.5.1 Mallinckrodt Profile
Table Mallinckrodt Overview List
4.5.2 Mallinckrodt Products & Services
4.5.3 Mallinckrodt Business Operation Conditions
Table Business Operation of Mallinckrodt (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Eli Lilly (Company Profile, Sales Data etc.)
4.6.1 Eli Lilly Profile
Table Eli Lilly Overview List
4.6.2 Eli Lilly Products & Services
4.6.3 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Bracco Imaging (Company Profile, Sales Data etc.)
4.7.1 Bracco Imaging Profile
Table Bracco Imaging Overview List
4.7.2 Bracco Imaging Products & Services
4.7.3 Bracco Imaging Business Operation Conditions
Table Business Operation of Bracco Imaging (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 SIEMENS (Company Profile, Sales Data etc.)
4.8.1 SIEMENS Profile
Table SIEMENS Overview List
4.8.2 SIEMENS Products & Services
4.8.3 SIEMENS Business Operation Conditions
Table Business Operation of SIEMENS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Navidea (Company Profile, Sales Data etc.)
4.9.1 Navidea Profile
Table Navidea Overview List
4.9.2 Navidea Products & Services
4.9.3 Navidea Business Operation Conditions
Table Business Operation of Navidea (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Nordion (Company Profile, Sales Data etc.)
4.10.1 Nordion Profile
Table Nordion Overview List
4.10.2 Nordion Products & Services
4.10.3 Nordion Business Operation Conditions
Table Business Operation of Nordion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 IBA Group (Company Profile, Sales Data etc.)
4.11.1 IBA Group Profile
Table IBA Group Overview List
4.11.2 IBA Group Products & Services
4.11.3 IBA Group Business Operation Conditions
Table Business Operation of IBA Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Jubilant Pharma (Company Profile, Sales Data etc.)
4.12.1 Jubilant Pharma Profile
Table Jubilant Pharma Overview List
4.12.2 Jubilant Pharma Products & Services
4.12.3 Jubilant Pharma Business Operation Conditions
Table Business Operation of Jubilant Pharma (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Radiopharmaceutical Sales Revenue 2016-2020, by Company, in USD Million
Table Global Radiopharmaceutical Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Radiopharmaceutical Sales Revenue Share in 2020, by Company, in USD Million
5.2 Regional Market by Company
Figure North America Radiopharmaceutical Market Concentration, in 2020
Figure Europe Radiopharmaceutical Market Market Concentration, in 2020
Figure Asia-Pacific Radiopharmaceutical MMarket Concentration, in 2020
Figure South America Radiopharmaceutical Market Concentration, in 2020
Figure Middle East & Africa Radiopharmaceutical Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Oncology
Figure Radiopharmaceutical Demand in Oncology, 2016-2020, in USD Million
6.1.2 Demand in Cardiology
Figure Radiopharmaceutical Demand in Cardiology, 2016-2020, in USD Million
6.1.3 Demand in Others
Figure Radiopharmaceutical Demand in Others, 2016-2020, in USD Million
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Radiopharmaceutical Demand Forecast 2021-2026, by Application, in USD Million
Figure Radiopharmaceutical Market Growth 2021-2026, by Application, in USD Million
Figure Radiopharmaceutical Market Share in 2026, by Application, in USD Million
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Radiopharmaceutical Production 2016-2020, by Region, in USD Million
7.2 Regional Market
Table Global Radiopharmaceutical Market 2016-2020, by Region, in USD Million
Table Global Radiopharmaceutical Market Share 2016-2020, by Region, in USD Million
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Radiopharmaceutical Market Size and Growth 2016-2020, in USD Million
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Radiopharmaceutical Market Size 2016-2020, by Country, in USD Million
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Radiopharmaceutical Market Size and Growth 2016-2020, in USD Million
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Radiopharmaceutical Market Size 2016-2020, by Country, in USD Million
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Radiopharmaceutical Market Size and Growth 2016-2020, in USD Million
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Radiopharmaceutical Market Size 2016-2020, by Country, in USD Million
7.3.4 South America
7.3.4.1 Overview
Figure South America Radiopharmaceutical Market Size and Growth 2016-2020, in USD Million
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Radiopharmaceutical Market Size 2016-2020, by Country, in USD Million
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Radiopharmaceutical Market Size and Growth 2016-2020, in USD Million
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Radiopharmaceutical Market Size 2016-2020, by Country, in USD Million
7.4 Regional Import & Export
7.5 Regional Forecast
Table Radiopharmaceutical Market Forecast 2021-2026, by Region, in USD Million
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion